Results: PCBD and PGD trajectories determined by growth mixture modeling, each captured three primary outcomes: resilience, moderate-improving symptoms, and prolongedstable symptoms. The PGD solution also identified trajectories of increasing and decreasing distress: prolonged-worsening and acute-recovering symptoms. Prediction of 25-month outcomes indicated differences conforming to the severity of PGD symptoms, and the prolonged-worsening trajectory was associated with the worst adjustment.
12 months for PCBD (part of criteria B and C). However, many bereaved individuals will endorse fluctuating symptoms over time without being good diagnostic candidates (Maercker et al., 2013) , with considerable evidence for heterogeneous symptom patterns other than prolonged grief (Bonanno et al., 2002; Galatzer-Levy & Bonanno, 2012; Maccallum, Galatzer-Levy, & Bonanno, 2015) . Thus, the presence of unrelenting distress becomes a crucial characteristic when distinguishing bereavement-related pathology from normal grief.
Despite the importance of the temporal frame in defining griefrelated distress, no research has yet comparatively examined how well the symptom sets that comprise PGD and PCBD capture patterns of change over time. To have adequate specificity, it is essential for the diagnosis to differentiate the longitudinal course of prolonged grief from other culturally normative reactions. A quantitative approach to this end is the application of growth mixture modeling (GMM; Muthén & Muthén, 2019) . GMM has been extensively used in epidemiological and treatment investigations to distinguish heterogeneous trajectories of change over time, and to identify distinct subpopulations of individuals with chronic, acute, worsening, or improving symptoms (Bonanno et al., 2011; Bonanno et al., 2012; ; Galatzer-Levy, Huang, & Bonanno, 2018; Uher et al., 2010) A number of bereavement studies have utilized the GMM to identify heterogeneous trajectories of change in depression following loss (Bonanno, Papa, Moskowitz, & Folkman, 2005; Galatzer-Levy & Bonanno, 2012; Maccallum et al., 2015) . More recently, several studies have examined longitudinal trajectories of grief symptoms. Surprisingly, and at odds with the broader literature, the grief trajectories identified in these studies tended to show only minimal change over time. The reason for this divergence may be due in part to methodological limitations. Two of the grief trajectory studies (Lenferink, Nickerson, de Keijser, Smid, & Boelen, 2018; Nielsen, Carlsen, Neergaard, Bidstrup, & Guldin, 2018) used constrained forms of growth modeling that fixed all variance parameters to be identical within trajectory classes, thus excluding exploration of alternative modeling solutions (Nagin & Odgers, 2010) .
Another study (Sveen, Bergh Johannesson, Cernvall, & Arnberg, 2018) used the more flexible GMM approach, which allowed for random variance parameters. However, both this study and suffered from small sample sizes for GMM (Kim, 2012) and only examined data on grief after the first year of bereavement. Thus, these studies were unable to identify early patterns of longitudinal change.
Importantly, none of the grief trajectory studies examined the possibility that different sets of grief symptoms might vary in their capacity to capture change.
To address this critical question in the current investigation we examined longitudinal trajectories for both PGD and PCBD grief symptoms in a sample of adults who recently lost a spouse. We addressed previous limitations in grief trajectory studies by using GMM with a sufficiently large sample of individuals recruited from the community to ensure adequate heterogeneity in symptom presentation and to allow for exploration of a range of possible modeling solutions.
Crucially, we assessed grief symptoms at 3, 14, and 25 months postloss using structured clinical interviews, which allowed us to examine the course of symptoms at both early and later points in bereavement. To our knowledge, this is the first study to use GMM to examine growth trajectories of PCBD and PGD symptoms assessed with clinical interviews and the first to compare their differential outcomes. for whom data were available for at least two time points, and 206 participants completed all three sessions. Participants were on average 55.3 years of age (SD = 7.2), two-thirds female (66.0%), predominantly White (90.0%), with a college degree or above (60.8%), and working full time (61.5%).
| Structured clinical interviews
Participants were administered structured clinical interviews that included assessment of the presence/absence of 16 symptoms that comprised Prolonged Complicated Bereavement Disorder (PCBD) corresponding to the DSM-5 criteria (American Psychiatric Association, 2013), and 12 symptoms that comprised of PGD corresponding to the ICD-11 diagnostic criteria (WHO, 2018) . All PGD symptoms assessments were identical to those overlapping in the PCBD criteria (see Table 1 The ICD-11 PGD diagnosis only specifies the word denial for this symptom. On the basis of the common clinical understanding of denial as the refusal to accept reality, as if a painful event had not occurred, we measured denial in the current study as a difficulty remembering key aspects of loss due to the painful nature of the event. The coding of this symptom in our structured interview explicitly specified that the that the difficulty remembering should be due to the painful nature of the loss and not to the situational complexity or to the interviewees preoccupation or inability to attend/process the event. In other recent studies, Mauro et al. (2018) used the symptom "difficulty accepting the loss" as a proxy for denial. This symptom was also included in the current study. However, the ICD-11 criteria for PGD specify difficulty accepting the loss as a separate symptom from denial. Boelen et al. (2018) measured denial using the PCBD item, avoidance of places, objects, thoughts, or memories associated with the deceased. However, conceptually this symptom is closer to explicit avoidance than denial and was found to show poor sensitivity and low factor loadings. Because of the ambiguity surrounding this symptom, we tested whether our primary results would change without the denial symptom. Notably, however, the findings were essentially identical as when the denial symptom was included.
and posttraumatic stress disorder, as well as a number of other metrics.
Interviewers coded the presence/absence of each symptom. Symptom absence was further coded as either subthreshold or true absence, however, only the binary presence/absence distinction was used in the current study. A randomly selected set of five interviews were recoded for reliability. Interclass correlation (ICC = 0.94) for absolute agreement indicated high rater reliability.
| Outcome measures
Depression. Depression was measured using the Center for Epidemiological Studies-Depression (CES-D; Kohout, Berkman, Evans, & Cornoni-Huntley, 1993) , an 11-item self-report scale.
Functioning. Participants were assessed based on their overall psychological, social, and occupational functioning using the Global Assessment of Functioning scale (GAF; Jones, Thornicroft, Coffey, & Dunn, 1995) . GAF scores are considered a reliable method to measure outcomes at a group level (Söderberg, Tungström, & Armelius, 2005) . Inter-rater reliability was assessed as having three external trained raters, each recode GAF scores on random subsets of 20 participants with very high interclass correlation (ICC = 0.92) for absolute agreement.
Interviewer ratings of Patient Suffering. Interviewers were also asked to rank on a 7-point Likert scale the extent to which each participant was suffering during the interview (IRPS).
PCBD/PGD Prevalence. We assigned PCBD diagnosis using the criteria specified in DSM-5, with impaired functioning defined as GAF below 60.
Assigning caseness for PGD is less straightforward because "as the new ICD disorder definitions are based on a typological approach, there is no strict requirement for the number of symptoms needed to meet the diagnostic threshold" (Killikelly & Maercker, 2018) . Nonetheless, to facilitate empirical assessment of PGD, recent studies Mauro et al., 2018) have translated the ICD-11 description of PGD to specify an A criterion (the presence of either persistent yearning or intense preoccupation for the deceased), and a B criterion that requires at least one symptom of intense emotional pain (e.g., sadness, guilt, anger, denial, blame, difficulty accepting the death, feeling one has lost a part of one's self, an inability to experience positive mood, emotional numbness, difficulty in engaging with social or other activities; see Table 1 ). We used this algorithm in the current study, along with impaired functioning as defined above for PCBD. In addition, for exploratory purposes, we also considered two other PGD diagnostic algorithms: One with the B criterion defined by three or more symptoms (PGD 1+3 ) and one with the B criterion defined by five or more symptoms (PGD 1+5 ).
T A B L E 1 Symptoms comprising diagnosis for PCBD (DSM-5) and PGD (ICD-11)
Criteria symptom PCBD PGD Structured interview item match was based on these indices, explanatory properties, and theoretical coherence (Bonanno, 2004; Muthén, 2003) .
3 | RESULTS
| PCBD (DSM-5) symptoms
Fit statistics for unconditional models with two to four classes were compared (see Table 2 ). The information criteria (AIC, BIC, and SSABIC) decreased consistently, suggesting indicated increased fit with increasing class size. Entropy, as a measure of certainty in class membership assignment, was high for the 2-and 4-class (0.87)
solutions, but higher for the 3-class (0.91) solution. The adjusted LRT indicated significantly improved model fit from 1-to 2-class solutions and from 2-to 3-class solutions but did not approach significance for the 4-class solution (p = 0.63). Given these metrics, the 3-class model was clearly the optimal solution.
Examining the 3-class model further (see Figure 1a) , the majority of the sample (71%) was assigned to a trajectory indicative of
Resilience, characterized by low grief symptoms at 3 months (intercept = 2.22, SE = 0.02, p < 0.001) that declined slightly over time (slope = −0.76, SE = 0.12, p < 0.001). The second largest class (24%) 
| Comparing PCBD and PGD

Caseness overlap
Contingency analysis of 25-month caseness for PCBD and PDG resulted in a significant nonchance distribution, χ 
Trajectory overlap
The classification overlap between the two final trajectory solutions produced a significant nonchance distribution, χ 2 (8, N = 282) = 238.5, p < 0.001. However, as can be seen in Table 3 were also categorized in the PGD resilient trajectory. Of note, however, more than half of the PGD acute-recovery trajectory was misclassified in the PCBD analysis as a resilient trajectory of stable low grief (n = 10, 52.6%; res a = 1.8, p < 0.05).
Trajectories as predictors of T3 caseness and adjustment
The PGD trajectories outperformed the PCBD trajectories in matching diagnostic caseness (see Table 4 ). Although PCBD caseness was relatively infrequent (4.3%), only about two-thirds (68.6%) of all individuals classified in the Prolonged-Stable trajectory met PCBD criteria. By contrast, caseness for PGD was more frequent (11. 7%) and spread across the Prolonged-Worsening, Moderate-Stable, and et al., 2015) . Surprisingly, however, recent bereavement studies that examined trajectories of grief symptoms observed uncharacteristically flat trajectories that showed only minimal change over time Nielsen et al., 2018; Sveen et al., 2018) . As discussed earlier, this divergence from previous studies may be due in part to methodological limitations. In the current study, we addressed these methodological limitations but also examined whether the grief symptom sets might also inform sensitivity to change. Our findings demonstrate clearly that PGD (ICD-11) symptoms showed greater ability to capture change over time compared to PCBD (DSM-5) symptoms. Interestingly, although our study addressed the methodological limitations of previous grief trajectory studies, the findings for the PCBD trajectories were nonetheless similar to the findings of the previous studies. In our study, the best-fitting PCBD model produced three relatively flat parallel trajectories that were distinct at 3 months postloss but diverged only slightly over time.
These trajectories suggested outcomes of Resilience, ModerateImproving symptoms, and Prolonged-Stable grief symptoms. As can be seen in Figure 1 , the best-fitting PGD model identified a greater number of trajectories and also showed greater variation in symptom levels over time than did the PCBD trajectories. The PGD trajectories identified trajectories of Resilience and Moderate-Improving symptoms comparable to the PCBD analysis.
However, the PGD analysis also identified a second trajectory of moderate symptoms that remained stable over time and, crucially, two additional trajectories, not identified with PCBD symptoms. These were characterized by high early levels of grief symptoms that either increased further over time, the Prolongedworsening trajectory (4%), or dramatically decreased over time, and acute-recovery trajectory (7%). Of note, the variation in symptom severity over time revealed by these PGD two trajectories was not well-represented in the PCBD trajectories. Alternatively, the larger amount of PCBD symptoms could minimize the contribution of its more salient characteristics.
Analyses of PCBD symptoms using a network approach (Borsboom & Cramer, 2013) suggested that yearning and emotional pain (Maccallum, Malgaroli, & Bonanno, 2017; Robinaugh, Millner, & McNally, 2016) , as well as identity disruptions (Malgaroli et al., 2018) , are among its most central and defining characteristics. These elements more closely reflect PGD's smaller subset of symptoms, whereas the other additional and less-distinguishing PCBD symptoms (e.g., difficulty trusting others) may reflect more characterological phenomena less specifically related to grief course.
Our study has a number of strengths. Most notably, we used a flexible modeling approach, GMM, to explore possible trajectory solutions using a sample and design specifically tailored to longitudinal trajectory research, with symptoms measured through reliable clinical interviews. Despite these strengths, however, several limitations are worth noting. First, although the heterogeneity inherent in a community sample is ideal for latent trajectory analyses, the absolute numbers of individuals with elevated psychopathology were limited. Future trajectory research comparing different symptoms sets would, therefore, benefit from the use of both community and clinical samples. Second, relatedly, although the sample size for the current investigation was adequate for latent trajectory modeling (Kim, 2012) , even larger sample sizes would allow for greater exploration of psychopathological patterns. Third, it will be important to replicate the greater sensitivity to change we observed for the ICD-11 PGD symptoms. Because this symptom set has not previously been examined using GMM, further research is warranted. Fourth, in assigning caseness, we used a cut-score from the GAF to designate impairment. However, this measure does not specifically reference impairment due to grief symptoms. Finally, it is worth acknowledging that although latent growth mixture modeling of symptom trajectories tells us a great deal about how well symptom sets capture change over time, this approach cannot interrogate the crucial distinction in psychiatric diagnoses between mandatory and accessory symptoms.
Overall, PGD symptoms better-captured psychopathology and associated outcomes and were more sensitive to change over time when compared to PCBD. The suggested spuriousness of PCBD could result in a decreased diagnostic utility, as indicated by previous studies showing a nonadequate sensitivity in clinical and community samples (Cozza et al., 2016; Mauro et al., 2018) . Ultimately, more research on bereavement outcomes is needed to better understand heterogeneity in the fluctuations of grief symptoms over time.
Experience sampling methods, for example, would allow a more finegrained temporal analysis of prolonged grief, offering insights on symptoms interactions and on the appropriate inclusion/exclusion criteria. In the meantime, the available empirical evidence and the findings from the current study argue in favor of the clinical utility of the more concise set of PGD symptoms.
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